The Silent Threat — Why Early Lymphedema Detection Matters for Breast Cancer Survivors

By the time lymphedema is visible — it’s often too late to reverse. For breast cancer survivors, that’s the difference between a manageable risk and a lifelong condition. In a new MedCity News article, Steven Chen, MD, MBA makes the case for shifting lymphedema care upstream — to detection before symptoms appear.

Read Now